ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.96
-0.33 (-4.53%)
At close: Apr 28, 2026, 4:00 PM EDT
7.00
+0.04 (0.57%)
After-hours: Apr 28, 2026, 5:51 PM EDT
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $7.19 billion as of April 28, 2026. Its market cap has increased by 231.10% in one year.
Market Cap
7.19B
Enterprise Value
7.79B
1-Year Change
231.10%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $7.19B, a decrease of -51.51%. That is a compound annual growth rate of -13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.53B | 286.03% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 8.57B |
| Vaxcyte | 8.53B |
| Nuvalent | 8.30B |
| Krystal Biotech | 8.09B |
| Cytokinetics | 7.85B |
| Halozyme Therapeutics | 7.78B |
| Kymera Therapeutics | 7.26B |
| Arcellx | 6.75B |